FOIA to FDA Seeking Assessments of the Impact of Coronavirus Testing Limitation Decisions

FOIA to the Department of Health and Human Services’ (HHS) Food and Drug Administration (FDA) seeking records reflecting communications about the impact of decisions that affected the availability of coronavirus testing in the United States.


Part of Investigation: